BofA Securities Reiterates Buy Rating on Gilead Sciences (GILD) as weekly Yeztugo scripts accelerate
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad reiterated a Buy rating and $162.00 price target on Gilead Sciences (NASDAQ: GILD)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
